Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1and CD4 down-regulation

Citation
B. Peng et M. Robert-guroff, Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1and CD4 down-regulation, IMMUNOL LET, 78(3), 2001, pp. 195-200
Citations number
27
Categorie Soggetti
Immunology
Journal title
IMMUNOLOGY LETTERS
ISSN journal
01652478 → ACNP
Volume
78
Issue
3
Year of publication
2001
Pages
195 - 200
Database
ISI
SICI code
0165-2478(20011001)78:3<195:DONMSO>2.0.ZU;2-O
Abstract
HIV-1 Nef is a desirable vaccine component because it is expressed early an d abundantly during HIV infection, and contains many CTL, T-helper cell, an d B-cell epitopes. Nef, however, down-regulates MHC-1 and CD4 cell surface expression, contributing to viral escape from host immunity. To prevent Nef from down-regulating both MHC-1 and CD4 while preserving most CTL epitopes , a panel of Nef mutants was constructed and assessed. Some mutants, as exp ected, modulated either MHC-1 or CD4 expression, Others prevented down-regu lation of both proteins but sacrificed numerous immunogenic epitopes. Delet ion of 19 N-terminal amino acids including the myristoylation signal from N ef completely abrogated both MHC-1 and CD4 down-regulation while preserving most CTL, T-helper and B-cell epitopes. Our results demonstrate that the m yristoylation signal in the Nef protein is critical for Nef-mediated endocy tosis of both MHC-1 and CD4. Non-myristoylated Nef containing a full comple ment of CTL epitopes has greater potential as a vaccine component than wild -type Nef. (C) 2001 Elsevier Science B.V. All rights reserved.